The Valley Desk

NCT02953509 · Interventional trial

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Non Hodgkin Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov